CompRest - a Comparison Between Sleep Compression and Sleep Restriction for Treating Insomnia
CompRest
CompRest - a Randomized Comparison Between Sleep Compression and Sleep Restriction for the Treatment of Insomnia
1 other identifier
interventional
234
1 country
1
Brief Summary
This study includes two consecutive sub-trials. Cognitive Behavioral Therapy (CBT) is treatment of choice for Insomnia. One of the most important treatment Components in CBT for insomnia (CBT-i) is Sleep Restriction (SR), but lately, adverse effects related to SR have been reported. A treatment method with similarities to SR is Sleep Compression (SC). SC is not as well studied as SR, but appears to have similar effects to SR but without the adverse effects. The first sub-trial thus aims at directly comparing SR and SC. The second sub-trial aims at evaluating any additional effects of CBT-i components given as an add-on treatment to a randomized selection of half participants in each original treatment arm.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2016
CompletedFirst Posted
Study publicly available on registry
April 19, 2016
CompletedStudy Start
First participant enrolled
July 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedSeptember 9, 2022
September 1, 2022
3.9 years
April 12, 2016
September 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Insomnia Severity Index (ISI)
7-item, self-rated questionnaire measuring change in insomnia severity. Bastien, C. H., Vallières, A., \& Morin, C. M. (2001). Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine, 2, 297-307.
Change from base-line to 5 weeks, 10 weeks, 20 weeks and 57 weeks
Secondary Outcomes (4)
Sleep diary
Continuously from one week before treatment start (-1 week) to the last week of treatment (week 10)
Actigraphy
Continuously from one week before treatment start (-1 week) to the last week of treatment (week 10)
Adverse Events
Week 2, week 4 and week 5
Sleep Problems Acceptance Questionnaire
Change from base-line to 5 weeks, 10 weeks, 20 weeks and 57 weeks
Other Outcomes (1)
Polysomnography
One week before treatment (Week -1) and at week 1, week 3, week 5, and week 10
Study Arms (4)
Sleep Restriction followed by additional CBT-i components
EXPERIMENTALSleep Restriction treatment during 5+5 weeks. Followed by being offered an additional intervention consisting of other ICBT-i components during 10 weeks.
Sleep Compression followed by additional CBT-i components
ACTIVE COMPARATORSleep Compression treatment during 5+5 weeks. Followed by being offered an additional intervention consisting of other ICBT-i components during 10 weeks.
Sleep Restriction followed by no intervention
ACTIVE COMPARATORSleep Restriction treatment during 5+5 weeks. Followed by NOT being offered or informed of an additional intervention consisting of other ICBT-i components during 10 weeks.
Sleep Compression followed by no intervention
ACTIVE COMPARATORSleep Compression treatment during 5+5 weeks. Followed by NOT being offered or informed of an additional intervention consisting of other ICBT-i components during 10 weeks.
Interventions
Behavioral component of CBT-i. Sleep restrictions includes curtailing bed time to match sleep time as registered during the first week of treatment, and expanding bed time contingent upon increased sleep efficiency, until optimal balance between sleep time and sleep efficiency is reached. The first five weeks, therapist support is provided via written messages. The next five weeks, patient works independently. At the end of tenth treatment week, therapist and patient make plan for future.
Behavioral component of CBT-i. Sleep compression includes gradually compressing bed time over several weeks to approach sleep time as registered during the first week of treatment, and stopping compression when optimal balance between sleep time and sleep efficiency is reached. The first five weeks, therapist support is provided via written messages. The next five weeks, patient works independently. At the end of tenth treatment week, therapist and patient make plan for future.
After 5+5 weeks of either Sleep Restriction or Sleep Compression, a randomized sample from each treatment Group is offered additional components of CBT-i, such as Stimulus Control, Cognitive Restructuring, Relaxation and Visualization for 10 weeks, without therapist support. Component allocation based on individual analysis.
Eligibility Criteria
You may qualify if:
- Clinical level of Insomnia (more than 10 on ISI)
- Meets criteria for Insomnia Disorder according to DSM-V
- Sufficient language skills
- Having access to Internet to fill out forms and participating in treatment
- Not foresee obstacles to participating in treatment during the coming 20 weeks, or participating in measurements during the coming year.
You may not qualify if:
- Sleep disorders requiring other treatment
- High consumption of alcohol/drugs that affect sleep
- Somatic or psychiatric conditions counter-indicative of treatments given in the study, requiring acute care, or with symptoms and level of functioning affecting the ability to participate in the treatment programs.
- Working (night) shifts
- Ongoing psychological treatment for Insomnia with sleep restriction or sleep compression as a treatment component - also previous such treatment can be excluding
- Use of sleep medication in such a way that may hinder the implementation of the methods in this treatment
- Pre-treatment measurements not finished within the given time-frame.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Internetpsykiatrienheten (Internet Psychiatry Clinic) Psykiatri Sydväst, SLSO
Stockholm, 14186, Sweden
Related Publications (2)
Jernelov S, Rosen A, Forsell E, Blom K, Ivanova E, Maurex L, Jansson-Frojmark M, Akerstedt T, Kaldo V. Is sleep compression therapy non-inferior to sleep restriction therapy? A single-blind randomized controlled non-inferiority trial comparing sleep compression therapy to sleep restriction therapy as treatment for insomnia. Sleep. 2025 Aug 14;48(8):zsaf093. doi: 10.1093/sleep/zsaf093.
PMID: 40205789DERIVEDKraepelien M, Blom K, Forsell E, Hentati Isacsson N, Bjurner P, Morin CM, Jernelov S, Kaldo V. A very brief self-report scale for measuring insomnia severity using two items from the Insomnia Severity Index - development and validation in a clinical population. Sleep Med. 2021 May;81:365-374. doi: 10.1016/j.sleep.2021.03.003. Epub 2021 Mar 16.
PMID: 33813233DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susanna Jernelöv, PhD
Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Group Leader
Study Record Dates
First Submitted
April 12, 2016
First Posted
April 19, 2016
Study Start
July 1, 2016
Primary Completion
June 1, 2020
Study Completion
June 1, 2020
Last Updated
September 9, 2022
Record last verified: 2022-09